Ypsomed Holding AG Cash Flow Conversion Efficiency
Ypsomed Holding AG cash flow conversion efficiency. Based on the latest financial reports, Ypsomed Holding AG (YPSN) has a cash flow conversion efficiency ratio of 0.162x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF130.38 Million ≈ $164.83 Million USD) by net assets (CHF807.19 Million ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Ypsomed Holding AG (2002–2025)
Cash flow conversion efficiency of Ypsomed Holding AG from 2002 to 2025. This chart illustrates how Ypsomed Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Ypsomed Holding AG (YPSN) share price today for real-time trading data and today's change.
Ypsomed Holding AG Cash Flow Conversion Ratio Explained
Ypsomed Holding AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Ypsomed Holding AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ypsomed Holding AG ranked by their cash flow conversion efficiency. Also see Ypsomed Holding AG (YPSN) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Longfor Group Holdings Limited
F:RLF
|
0.027x |
|
Alaska Air Group Inc
NYSE:ALK
|
0.113x |
|
TRI Pointe Homes Inc
NYSE:TPH
|
0.067x |
|
Vontobel Holding
SW:VONN
|
0.544x |
|
KRONES AG(UNSP.ADR)1/2/ON
F:KRNU
|
0.035x |
|
Energisa S.A
SA:ENGI11
|
-0.079x |
|
Banco Macro S.A
F:B4W
|
0.108x |
|
Cosan SA ADR
NYSE:CSAN
|
0.029x |
Annual Cash Flow Conversion Efficiency for Ypsomed Holding AG (2002–2025)
The table below shows the annual cash flow conversion efficiency of Ypsomed Holding AG from 2002 to 2025. Review Ypsomed Holding AG free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | CHF679.68 Million ≈ $859.31 Million |
CHF148.20 Million ≈ $187.36 Million |
0.218x | -17.48% |
| 2024-03-31 | CHF617.73 Million ≈ $780.98 Million |
CHF163.22 Million ≈ $206.36 Million |
0.264x | +14.71% |
| 2023-03-31 | CHF562.33 Million ≈ $710.94 Million |
CHF129.53 Million ≈ $163.76 Million |
0.230x | +5.50% |
| 2022-03-31 | CHF392.54 Million ≈ $496.28 Million |
CHF85.71 Million ≈ $108.36 Million |
0.218x | +0.58% |
| 2021-03-31 | CHF395.38 Million ≈ $499.87 Million |
CHF85.83 Million ≈ $108.51 Million |
0.217x | +70.40% |
| 2020-03-31 | CHF385.35 Million ≈ $487.18 Million |
CHF49.09 Million ≈ $62.06 Million |
0.127x | -19.38% |
| 2019-03-31 | CHF378.80 Million ≈ $478.91 Million |
CHF59.86 Million ≈ $75.68 Million |
0.158x | +1.32% |
| 2018-03-31 | CHF341.54 Million ≈ $431.80 Million |
CHF53.27 Million ≈ $67.35 Million |
0.156x | -37.29% |
| 2017-03-31 | CHF301.80 Million ≈ $381.55 Million |
CHF75.06 Million ≈ $94.90 Million |
0.249x | -13.13% |
| 2016-03-31 | CHF267.84 Million ≈ $338.62 Million |
CHF76.69 Million ≈ $96.95 Million |
0.286x | +66.50% |
| 2015-03-31 | CHF240.64 Million ≈ $304.23 Million |
CHF41.38 Million ≈ $52.32 Million |
0.172x | -4.78% |
| 2014-03-31 | CHF228.16 Million ≈ $288.46 Million |
CHF41.21 Million ≈ $52.10 Million |
0.181x | +158.82% |
| 2013-03-31 | CHF217.37 Million ≈ $274.82 Million |
CHF15.17 Million ≈ $19.18 Million |
0.070x | -51.02% |
| 2012-03-31 | CHF218.00 Million ≈ $275.61 Million |
CHF31.05 Million ≈ $39.26 Million |
0.142x | +159.79% |
| 2011-03-31 | CHF538.06 Million ≈ $680.25 Million |
CHF29.50 Million ≈ $37.30 Million |
0.055x | +31.17% |
| 2010-03-31 | CHF537.74 Million ≈ $679.85 Million |
CHF22.48 Million ≈ $28.42 Million |
0.042x | -62.26% |
| 2009-03-31 | CHF437.03 Million ≈ $552.53 Million |
CHF48.40 Million ≈ $61.20 Million |
0.111x | -34.08% |
| 2008-03-31 | CHF417.58 Million ≈ $527.93 Million |
CHF70.16 Million ≈ $88.69 Million |
0.168x | +111.65% |
| 2007-03-31 | CHF390.03 Million ≈ $493.10 Million |
CHF30.96 Million ≈ $39.14 Million |
0.079x | -30.83% |
| 2006-03-31 | CHF404.01 Million ≈ $510.78 Million |
CHF46.37 Million ≈ $58.62 Million |
0.115x | -56.75% |
| 2005-03-31 | CHF357.17 Million ≈ $451.56 Million |
CHF94.78 Million ≈ $119.82 Million |
0.265x | -88.16% |
| 2004-03-31 | CHF11.84 Million ≈ $14.97 Million |
CHF26.54 Million ≈ $33.55 Million |
2.241x | +1127.06% |
| 2003-03-31 | CHF111.68 Million ≈ $141.20 Million |
CHF20.40 Million ≈ $25.79 Million |
0.183x | +168.73% |
| 2002-03-31 | CHF95.58 Million ≈ $120.84 Million |
CHF6.50 Million ≈ $8.21 Million |
0.068x | -- |
About Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable inje… Read more